Selected research
Market Outlook & Growth Opportunities
Global Custom Assay Development Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Custom Assay Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Custom Assay Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Custom Assay Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Custom Assay Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Custom Assay Development Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Custom Assay Development Service market include Eurofins Scientific, PerkinElmer, Champions Oncology, Inc, Precision for Medicine, Sygnature Discovery, Merck KGaA, Plexbio, Cygnus Technologies and Luminex Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Custom Assay Development Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Custom Assay Development Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Custom Assay Development Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Assay Development Service market.
Custom Assay Development Service Segment by Company
Eurofins Scientific
PerkinElmer
Champions Oncology, Inc
Precision for Medicine
Sygnature Discovery
Merck KGaA
Plexbio
Cygnus Technologies
Luminex Corporation
Gyros Protein Technologies AB
Mission Bio
Camtech Innovations
ProteoGenix
Selvita
Multispan, Inc.
Capra Science
Agena Bioscience, Inc.
Celemics, Inc.
Custom Assay Development Service Segment by Type
Cell-based
Antibody-based
Others
Custom Assay Development Service Segment by Application
Pharmacy
Biology
Scientific Research
Others
Custom Assay Development Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Custom Assay Development Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Custom Assay Development Service key companies, revenue, market share, and recent developments.
3. To split the Custom Assay Development Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Custom Assay Development Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Custom Assay Development Service significant trends, drivers, influence factors in global and regions.
6. To analyze Custom Assay Development Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Assay Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Assay Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Assay Development Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Assay Development Service industry.
Chapter 3: Detailed analysis of Custom Assay Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Custom Assay Development Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Custom Assay Development Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cell-based
- Antibody-based
- Others
Applications
- Pharmacy
- Biology
- Scientific Research
- Others
Companies covered
- Eurofins Scientific
- PerkinElmer
- Champions Oncology, Inc
- Precision for Medicine
- Sygnature Discovery
- Merck KGaA
- Plexbio
- Cygnus Technologies
- Luminex Corporation
- Gyros Protein Technologies AB
- Mission Bio
- Camtech Innovations
- ProteoGenix
- Selvita
- Multispan, Inc.
- Capra Science
- Agena Bioscience, Inc.
- Celemics, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Custom Assay Development Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Custom Assay Development Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Custom Assay Development Service Market Dynamics
- 2.1 Custom Assay Development Service Industry Trends
- 2.2 Custom Assay Development Service Industry Drivers
- 2.3 Custom Assay Development Service Industry Opportunities and Challenges
- 2.4 Custom Assay Development Service Industry Restraints
3 Custom Assay Development Service Market by Company
- 3.1 Global Custom Assay Development Service Company Revenue Ranking in 2025
- 3.2 Global Custom Assay Development Service Revenue by Company (2021-2026)
- 3.3 Global Custom Assay Development Service Company Ranking (2024-2026)
- 3.4 Global Custom Assay Development Service Company Manufacturing Base and Headquarters
- 3.5 Global Custom Assay Development Service Company Product Type and Application
- 3.6 Global Custom Assay Development Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Custom Assay Development Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Custom Assay Development Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Custom Assay Development Service Market by Type
- 4.1 Custom Assay Development Service Type Introduction
- 4.1.1 Cell-based
- 4.1.2 Antibody-based
- 4.1.3 Others
- 4.2 Global Custom Assay Development Service Sales Value by Type
- 4.2.1 Global Custom Assay Development Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Custom Assay Development Service Sales Value by Type (2021-2032)
- 4.2.3 Global Custom Assay Development Service Sales Value Share by Type (2021-2032)
5 Custom Assay Development Service Market by Application
- 5.1 Custom Assay Development Service Application Introduction
- 5.1.1 Pharmacy
- 5.1.2 Biology
- 5.1.3 Scientific Research
- 5.1.4 Others
- 5.2 Global Custom Assay Development Service Sales Value by Application
- 5.2.1 Global Custom Assay Development Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Custom Assay Development Service Sales Value by Application (2021-2032)
- 5.2.3 Global Custom Assay Development Service Sales Value Share by Application (2021-2032)
6 Custom Assay Development Service Regional Value Analysis
- 6.1 Global Custom Assay Development Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Custom Assay Development Service Sales Value by Region (2021-2032)
- 6.2.1 Global Custom Assay Development Service Sales Value by Region: 2021-2026
- 6.2.2 Global Custom Assay Development Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Custom Assay Development Service Sales Value (2021-2032)
- 6.3.2 North America Custom Assay Development Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Custom Assay Development Service Sales Value (2021-2032)
- 6.4.2 Europe Custom Assay Development Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Custom Assay Development Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Custom Assay Development Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Custom Assay Development Service Sales Value (2021-2032)
- 6.6.2 South America Custom Assay Development Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Custom Assay Development Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Custom Assay Development Service Sales Value Share by Country, 2025 VS 2032
7 Custom Assay Development Service Country-level Value Analysis
- 7.1 Global Custom Assay Development Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Custom Assay Development Service Sales Value by Country (2021-2032)
- 7.2.1 Global Custom Assay Development Service Sales Value by Country (2021-2026)
- 7.2.2 Global Custom Assay Development Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Custom Assay Development Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Custom Assay Development Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Custom Assay Development Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Eurofins Scientific
- 8.1.1 Eurofins Scientific Company Information
- 8.1.2 Eurofins Scientific Business Overview
- 8.1.3 Eurofins Scientific Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Eurofins Scientific Custom Assay Development Service Product Portfolio
- 8.1.5 Eurofins Scientific Recent Developments
- 8.2 PerkinElmer
- 8.2.1 PerkinElmer Company Information
- 8.2.2 PerkinElmer Business Overview
- 8.2.3 PerkinElmer Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.2.4 PerkinElmer Custom Assay Development Service Product Portfolio
- 8.2.5 PerkinElmer Recent Developments
- 8.3 Champions Oncology, Inc
- 8.3.1 Champions Oncology, Inc Company Information
- 8.3.2 Champions Oncology, Inc Business Overview
- 8.3.3 Champions Oncology, Inc Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Champions Oncology, Inc Custom Assay Development Service Product Portfolio
- 8.3.5 Champions Oncology, Inc Recent Developments
- 8.4 Precision for Medicine
- 8.4.1 Precision for Medicine Company Information
- 8.4.2 Precision for Medicine Business Overview
- 8.4.3 Precision for Medicine Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Precision for Medicine Custom Assay Development Service Product Portfolio
- 8.4.5 Precision for Medicine Recent Developments
- 8.5 Sygnature Discovery
- 8.5.1 Sygnature Discovery Company Information
- 8.5.2 Sygnature Discovery Business Overview
- 8.5.3 Sygnature Discovery Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Sygnature Discovery Custom Assay Development Service Product Portfolio
- 8.5.5 Sygnature Discovery Recent Developments
- 8.6 Merck KGaA
- 8.6.1 Merck KGaA Company Information
- 8.6.2 Merck KGaA Business Overview
- 8.6.3 Merck KGaA Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Merck KGaA Custom Assay Development Service Product Portfolio
- 8.6.5 Merck KGaA Recent Developments
- 8.7 Plexbio
- 8.7.1 Plexbio Company Information
- 8.7.2 Plexbio Business Overview
- 8.7.3 Plexbio Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Plexbio Custom Assay Development Service Product Portfolio
- 8.7.5 Plexbio Recent Developments
- 8.8 Cygnus Technologies
- 8.8.1 Cygnus Technologies Company Information
- 8.8.2 Cygnus Technologies Business Overview
- 8.8.3 Cygnus Technologies Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Cygnus Technologies Custom Assay Development Service Product Portfolio
- 8.8.5 Cygnus Technologies Recent Developments
- 8.9 Luminex Corporation
- 8.9.1 Luminex Corporation Company Information
- 8.9.2 Luminex Corporation Business Overview
- 8.9.3 Luminex Corporation Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Luminex Corporation Custom Assay Development Service Product Portfolio
- 8.9.5 Luminex Corporation Recent Developments
- 8.10 Gyros Protein Technologies AB
- 8.10.1 Gyros Protein Technologies AB Company Information
- 8.10.2 Gyros Protein Technologies AB Business Overview
- 8.10.3 Gyros Protein Technologies AB Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Gyros Protein Technologies AB Custom Assay Development Service Product Portfolio
- 8.10.5 Gyros Protein Technologies AB Recent Developments
- 8.11 Mission Bio
- 8.11.1 Mission Bio Company Information
- 8.11.2 Mission Bio Business Overview
- 8.11.3 Mission Bio Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Mission Bio Custom Assay Development Service Product Portfolio
- 8.11.5 Mission Bio Recent Developments
- 8.12 Camtech Innovations
- 8.12.1 Camtech Innovations Company Information
- 8.12.2 Camtech Innovations Business Overview
- 8.12.3 Camtech Innovations Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Camtech Innovations Custom Assay Development Service Product Portfolio
- 8.12.5 Camtech Innovations Recent Developments
- 8.13 ProteoGenix
- 8.13.1 ProteoGenix Company Information
- 8.13.2 ProteoGenix Business Overview
- 8.13.3 ProteoGenix Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.13.4 ProteoGenix Custom Assay Development Service Product Portfolio
- 8.13.5 ProteoGenix Recent Developments
- 8.14 Selvita
- 8.14.1 Selvita Company Information
- 8.14.2 Selvita Business Overview
- 8.14.3 Selvita Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Selvita Custom Assay Development Service Product Portfolio
- 8.14.5 Selvita Recent Developments
- 8.15 Multispan, Inc.
- 8.15.1 Multispan, Inc. Company Information
- 8.15.2 Multispan, Inc. Business Overview
- 8.15.3 Multispan, Inc. Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Multispan, Inc. Custom Assay Development Service Product Portfolio
- 8.15.5 Multispan, Inc. Recent Developments
- 8.16 Capra Science
- 8.16.1 Capra Science Company Information
- 8.16.2 Capra Science Business Overview
- 8.16.3 Capra Science Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Capra Science Custom Assay Development Service Product Portfolio
- 8.16.5 Capra Science Recent Developments
- 8.17 Agena Bioscience, Inc.
- 8.17.1 Agena Bioscience, Inc. Company Information
- 8.17.2 Agena Bioscience, Inc. Business Overview
- 8.17.3 Agena Bioscience, Inc. Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Agena Bioscience, Inc. Custom Assay Development Service Product Portfolio
- 8.17.5 Agena Bioscience, Inc. Recent Developments
- 8.18 Celemics, Inc.
- 8.18.1 Celemics, Inc. Company Information
- 8.18.2 Celemics, Inc. Business Overview
- 8.18.3 Celemics, Inc. Custom Assay Development Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Celemics, Inc. Custom Assay Development Service Product Portfolio
- 8.18.5 Celemics, Inc. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst